Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$143.93
▼ $0.78 (−0.54%) today
Markets closed · 2:00am ET

MRK Coverage

Page 68
2:54am ET
Media

Media Digest 7/24/2009 Reuters, WSJ, NYTimes, FT. Bloomberg

Reuters: Microsoft’s (MSFT) results and forecast were weak. Reuters:   CIT (CIT) may sell its aviation finance business. Reuters:   Fatigue at the Fed is leading to questions about its expanded role. Reuters:   Twitter…

Douglas A. McIntyre
4:01am ET
Health and Healthcare

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…

Douglas A. McIntyre
6:27am ET
Investing

DJIA Component Earnings Trifecta (DD, MRK, UTX)

So far we have three DJIA components with earnings out.  DuPont (NYSE: DD), Merck & Co. (NYSE: MRK), United Technologies (NYSE: UTX) have all posted earnings.  So far there are no train…

Douglas A. McIntyre